A new artificial antigen of the hepatitis E virus

Journal of Immunoassay and Immunochemistry

Volumn 30, Issue 1, 2009, Pages 18-39

  Ulanova, T I ^a   Obriadina, A P ^a   Talekar, G ^b   Burkov, A N ^a   Fields, H A ^b   Khudyakov, Y E ^b  

^a RPC Diagnostic Systems   (Russian Federation)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Artificial antigen; Enzyme immunoassay; Hepatitis E

Indexed keywords

FCG 31; HEPATITIS E ANTIGEN; OLIGONUCLEOTIDE; RECOMBINANT ANTIGEN; SYNTHETIC ANTIGEN; UNCLASSIFIED DRUG; VN 12; VN 186; VN 219; VN 315; VN 368;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME IMMUNOASSAY; ENZYME SYNTHESIS; GENE EXPRESSION; HEPATITIS E VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PURIFICATION; RESTRICTION ENZYME ASSISTED LIGATION; SEQUENCE ANALYSIS; SERODIAGNOSIS; SERUM;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; HEPATITIS ANTIBODIES; HEPATITIS ANTIGENS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; VIRAL PROTEINS;

EID: 58149173886     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810802570269     Document Type: Article

References (50)

1. Harrison, T.J. Heaptitis E virus an update. Liver 1999, 19, 171-176.
2. Bradley D.W. Hepatitis E: Epidemiology, aetiology and molecular biology. Rev. Med. Virol. 1992, 2, 19-28.
3. Worm, H.C.; Schlauder, G.G.; Brandstatter, G. Hepatitis E and its emergence in non-endemic areas. Wien Klin. Wochenschr. 2002, 114 (15-16), 663-670.
4. Carl, M.; Isaacs, S.N.; Kaur, M.; He, J.; Tam, A.W.; Yarburg, P.O.; Reyes, G.R. Expression of hepatitis E virus putative structural proteins in recombinant vaccinia viruses. Clin. Diagn. Lab. Immunol. 1994, 1, 253-256.
5. Krawczynski, K.; Aggarwal, R.; Kamili, S. Hepatitis, E. Infect. Clin N. Amer. 2000, 14 (3), 669-687.
6. Koonin, E.V.; Gorbalenya, A.E.; Purdy, M.A.; Rozanov, M.N.; Reyes, G.R.; Bradley, D.W. Computer assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA 1992, 89, 8259-8263.
7. Lai, S.K.; Tulasiram, P.; Jameel, S. Expression and characterization of the hepatitis E virus ORF 3 protein in the methylotrophic yeast, Pichia pastoris. Gene 1997, 190, 63-67.
8. Kabrane Lazizi, Y.; Meng, X.J.; Purcell, R.H.; Emerson, S.U. Evidence that the genomic RNA of hepatitis E virus capped. J. Virol. 1999, 73, 8848-8850.
9. Berke, T.; Matson, D.O. Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch. Virol. 2000, 145 (7), 1421-1436.
10. Schlauder, G.G.; Mushahwar, I.K. Genetic heterogeneity of Hepatitis E Virus. J. Med. Virol. 2001, 65, 282-292.
11. Schlauder, G.G.; Desai, S.M.; Zanetti, A.R.; Tassopoulos, N.C.; Mushahwar, I.K. Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J. Med. Virol. 1999, 57 (3), 243-251.
12. Zanetti, A.R.; Schlauder, G.G.; Romano, L.; Tanzi, E.; Fabris, P.; Dawson, G.J.; Mushahwar, I.K. Identification of a novel variant of hepatitis E virus in Italy. J. Med. Virol. 1999, 57 (4), 356-360.
13. Waar, K.; Herremans, M.M.; Vennema, H.; Koopmans, M.P.; Benne, C.A. Hepatitis E is a cause of unexplained hepatitis in The Netherlands. J. Clin. Virol. 2005, 33 (2), 145-149.
14. Chau, K.H.; Dawson, G.J.; Bile, K.M.; Magnius, L.O.; Sjogren, M.H.; Mushawar, I.K. Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E infection. J. Med.Virol. 1993, 40, 334-338.
15. Dawson, G.J.; Chau, K.H.; Cabal, C.M.; Yarburg, P.O.; Reyes, G.R.; Mushavar, I.K. Solidphase enzymelinked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Meth. 1992, 38, 175-186.
16. Favorov, M.O.; Khudyakov, Y.E.; Mast, E.E.; Yashina, T.L.; Shapiro, C.N.; Khudyakova, N.S.; Jue, D.L.; Onischenko, G.G.; Margolis, H.S.; Fields, H.A. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme im munoassay based on an HEV specific artificial recombinant mosaic protein. J. Med. Virol. 1996, 50, 50-58.
17. Fields, H.A.; Khudyakov, Y.E.; Favorov, M.O.; Khudyakova, N.S.; Cong, M.; Holloway, B.F.; Lambert, S.B.; Jue, L.D. Artificial mosaic proteins as new immunodiagnostic reagents: the hepatitis E virus experience. Clin. Diag. Virol. 1996, 5, 167-179.
18. Goldsmith, R.; Yarbourg, P.O.; Reyes, G.R.; Fry, K.E.; Gabor, K.A.; Kamel, M.; Zakaria, S.; Amer, S.; Gaffar, Y. Enzymelinked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992, 339, 328-331.
19. Lok, A.S.F.; Kwan, W.K.; Moeckli, R.; Yarbourg, P.O.; Chan, R.T.; Reyes, G.R.; Lai, C.L.; Chung, H.T.; Lai, T.S.T. Seroepodemiological survey of hepa titis E in Hong Kong by recombinantbased enzyme immunoassays. Lancet 1992, 340, 1205-1208.
20. Mast, E.E.; Alter, M.J.; Holland, P.V.; Purcell, R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody serum panel evaluation group. Hepatology 1998, 27, 857-861.
21. Yarbough, P.O.; Garza, E.; Tam, A.W.; Zhang, Y.; McAtee, P.; Fueerest, TR. Assay development of diagnostic tests for IgM and IgG antibody to hepati tis E virus; in Buisson Y.P., Coursaget P., Kane M: Enterically Transmitted Hepatitis viruses. JouelesTours, La Simarre 1996, 294-296.
22. Yarburgh, P.O.; Tam, A.W.; Fry, K.E.; Krawczynski, K. Hepatitis E virus: identification of typecomon epitopes. J. Virol. 1991, 5, 5790-5797.
23. Zhang, J.Z.; Stanley, W.K.; Lau, S.H.; Chau, T.N.; Lai, S.T.; Ng, S.P.; Malik, P.C.; Tse Ng, T.K.; Ng, M.H. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of nonA, B, and C acute hepatitis. J. Med. Virol. 2002, 6, 40-48.
24. Khudyakov, Y.E.; Khudyakova, N.S.; Fields, H.A.; Jue, D.; Starling, C.; Favorov, M.O.; Krawczynski, K.; Polish, L.; Mast, E.; Margolis, H. Epitope mapping in proteins of hepatitis E virus. Virology 1993, 194, 89-96.
25. Khudyakov, Y.E.; Favorov, M.O.; Jue, D.L.; Hine, T.K.; Fields, H.A. Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology 1994, 98, 390-393.
26. He, J.; Ching, W.M.; Yarbough, P.; Wang, H.; Carl, M. Purification of a baculovirus-expressed hepatitis E virus structural protein and utility in an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1995, 12, 3308-3311.
27. Li, F.; Torresi, J.; Locarnini, S.A.; Zhuang, H.; Zhu, W.; Guo, X.; Anderson, D.A. Aminoterminal epitopes are exposed when fulllength open reading 2 of he patitis E virus is expressed in Escherichia coli, but carboxyterminal epitopes are masked. J. Med. Virol. 1997, 52, 289-300.
28. Khudyakov, Y.E.; Favorov, M.O.; Khudyakova, N.S.; Gong, M.-E.; Holloway, B.P.; Padhye, N.; Lambert, S.B.; Jue, D.L.; Fields, H.A. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J. Virol. 1994, 68 (11), 7067-7074.
29. Cousaget, P.; Buisson, Y.; Depril, N.; Cann, P.; Chabaud, M.; Molinie, C.; Roul, R. Mapping of linear B cell epitopes on open reading frames 2 and 3 encoded proteins of hepatitis E virus using synthetic peptides. FEMS Microbiol. Lett. 1993, 109, 251-255.
30. Ichikawa, M.; Araki, M.; Rikhisa, T.; Uchida, T.; Shikata, T.; Mizuno, K. Cloning and expression of cDNAs from enterically transmitted nonA, nonB hepatitis virus. Microbiol. Immunol. 1991, 35, 535-543.
31. Kaur, M.; Hyams, K.C.; Purdy, M.A.; Krawzchinski, K.; Ching, W.M.; Fry, K.E.; Reyes, G.R.; Bradley, D.W.; Carl, M. Human linear Bcell epitopes encoded by the hepatitis E virus include determinants in the RNAdependent RNA polymerase. Proc. Natl. Acad. Sci. USA 1992, 89, 3855-3858.
32. Khudyakov, Y.E.; Khudyakova, N.S.; Jue, D.L.; Wells, T.W.; Padhya, N.; Fields, H.A. Comparative characterization of antigenic epitopes in the immunodomi nant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus. J. Gen. Virol. 1994, 75 (Pt 3), 641-646.
33. Khudyakov, Y.E.; Lopareva, E.N.; Jue, D.L.; Crews, T.K.; Thygarajan, S.P.; Fields, H.A. Antigenic domains of the open reading frame 2 encoded protein of hepatitis E virus. J. Clin. Microbiol. 1999, 37 (9), 2853-2871.
34. Li, F.; Riddell, M.A.; Seow, H.F.; Takeda, N.; Miyamura, T.; Anderson, D.A. Recombinant subunit ORF2.1 antigen and induction of antibody against immu nodominant epitopes in the hepatitis E virus capsid protein. J. Med.Virol. 2000, 60, 379-386.
35. Li, F.; Zhuang, H.; Kolivas, S.; Locarnini, S.A.; Anderson, D.A. Persistent and transient antibody responses to hepatitis E virus detected by Western immuno blot using open reading frame 2 and 3 glutation Stransferase fusion proteins. J. Clin. Microbiol. 1994, 32, 2060-2066.
36. Schofield, D.J.; Glamann, J.; Emerson, S.U.; Purcell, R.H. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J. Virol. 2000, 74 (12), 554-855.
37. Chang J.C. Towards designer diagnostic antigens. In Artificial DNA: Methods and Applications; Khudyakov Y.E, Fields H.A., Eds.; CRC Press: Boca Raton, FL, 2002; 363-384.
38. Chang, J.C.; Ruedinger, B.; Cong, M.; Lambert, S.; Lopareva, E.; Purdy, M.; Holloway, B.P.; Jue, D.L.; Ofenloch, B.; Fields, H.A.; Khudyakov, Y.E. Artificial NS4 mosaic antigen of hepatitis C virus. J. Med. Virol. 1999, 59, 437-450.
39. Sambrook, J.; Fritsch, E.F.; Maniatis, T. Molecular Cloning; Cold Spring Harbor Laboratory Press: New York, 1988.
40. Smith, D.B.; Johnson, K.S. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S transferase. Gene 1988, 67 (1), 31-40.
41. Ptitsyn, O.B.; Finkelstein A.V. Theory of protein secondary structure and algorithm of its prediction. Biopolymers 1983, 22, 15-25.
42. Barany, G.; Merrifield, R.B. Solid-phase Peptide Synthesis. In The Peptides; Gross, E.; Meienhoter, J.; Eds.; Academic Press: New York, 1980; Vol. 1, 1-284.
43. Aichele, P.; Hengartner, H.; Zinkernagel, R.M.; Schulz, M. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 1990, 171 (5), 1815-1820.
44. Liu, W.; Chen, Y.H. High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins. Eur. J. Immunol. 2005, 35 (2), 505-514.
45. Irshad, M. Hepatitis E virus: an update on its molecular, clinical and epidemiological characteristics. Intervirology 2000, 42 (4), 252-262.
46. Obriadina, A.; Meng, J.; Ulanova, T.; Trinta, K.; Burkov, A.; Fields, H.; Khudyakov, Y. A new enzyme immunoassay for the detection of antibody to hepatitis E virus. J. Gastroenterol. Hepatol. 2002, 17 (Suppl. 3), S360-S364.
47. Riddell, M.A.; Li, F.; Anderson, D.A. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using mo noclonal antibodies. J. Virol. 2000, 74 (17), 8011-8017.
48. Zhang, Y.; McAtee, P.; Yarbough, P.O.; Tam, A.W.; Fuerst, T. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells. Clin. Diag. Lab. Immunol. 1997, 4 (4), 423-428.
49. Kumar, V.; Bansal, V.J.; Rao, K.V.; Jameel, S. Hepatitis B virus envelope epitopes: gene assembly and expression in Escherichia coli of an immunologically reactive novel multiple-epitope polypeptide 1 (MEP-1). Gene 1992, 110 (2), 137-144.
50. Yagi, S.; Kashiwakuma, T.; Yamaguchi, K.; Chiba, Y.; Ohtsuka, E.; Hasegawa, A. An epitope chimeric antigen for the hepatitis C virus serological screening test. Biol. Pharm. Bull. 1996, 19 (10), 1254-1260.